Table 2.
Variables | Number of patients (%) |
---|---|
Sex | |
Male | 20 (75) |
Female | 7 (25) |
Age (year) median (range) | 47 (22–70) |
WHO classification | |
Acute myeloid leukemia, minimally differentiated | 1 (4) |
Acute myeloid leukemia without maturation | 10 (37) |
Acute myeloid leukemia with maturation | 9 (33) |
Acute myelomonocytic leukemia | 6 (22) |
Acute monoblastic/acute monocytic leukemia | 1 (4) |
Karyotype* | |
Favourable | 0 (0) |
Intermediate | 14 (52) |
Unfavourable | 2 (8) |
Undetermined | 11 (40) |
CR after 1st remission induction therapy | 13 (48) |
HSCT** | 5 (18) |
Overall survival (months)*** | 9 (1–27) |
WHO world health classification, CR complete remission
* Favorable, t(8;21), inv(16); unfavourable, −7, del(7q), −5, del(5q), 3q abnormality, complex; intermediate, normal karyotype, and other abnormalities
** HSCT: Received allogeneic hematopoietic stem cell transplantation
*** Median (range)